 Hemostatic efficacy of the investigational product will be assessed by means of thromboelastographic measure of Maximum Clot Firmness MCF at baseline and one-hour post-infusion. Other thromboelastographic measures as well as standard coagulation tests will be also determined pre- and post-infusion. 